1. Home
  2. GPRE vs SPRY Comparison

GPRE vs SPRY Comparison

Compare GPRE & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Plains Inc.

GPRE

Green Plains Inc.

HOLD

Current Price

$14.91

Market Cap

812.2M

Sector

Industrials

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$9.59

Market Cap

788.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPRE
SPRY
Founded
2004
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
812.2M
788.5M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
GPRE
SPRY
Price
$14.91
$9.59
Analyst Decision
Buy
Strong Buy
Analyst Count
7
1
Target Price
$12.57
$40.00
AVG Volume (30 Days)
1.2M
1.7M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.42
N/A
Revenue
$2,091,680,000.00
$84,278,000.00
Revenue This Year
N/A
$87.40
Revenue Next Year
$11.85
$81.64
P/E Ratio
$35.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.63
$6.66
52 Week High
$18.94
$18.63

Technical Indicators

Market Signals
Indicator
GPRE
SPRY
Relative Strength Index (RSI) 41.02 60.95
Support Level $14.64 $9.50
Resistance Level $15.64 $10.44
Average True Range (ATR) 0.65 0.61
MACD -0.10 0.09
Stochastic Oscillator 28.41 88.42

Price Performance

Historical Comparison
GPRE
SPRY

About GPRE Green Plains Inc.

Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: